These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26815784)

  • 21. First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI.
    Semler O; Netzer C; Hoyer-Kuhn H; Becker J; Eysel P; Schoenau E
    J Musculoskelet Neuronal Interact; 2012 Sep; 12(3):183-8. PubMed ID: 22947550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of three adults and an adolescent with Osteogenesis Imperfecta type VI and a novel founder SERPINF1 variant.
    Travessa AM; Dias P; Rosmaninho-Salgado J; Aza-Carmona M; Moldovan O; Díaz-González F; Godinho F; Romeu JC; Oliveira-Ramos F; do Céu Barreiros M; Sousa SB; Heath KE; Sousa AB
    Eur J Med Genet; 2023 Nov; 66(11):104867. PubMed ID: 37839784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two years' experience with denosumab for children with osteogenesis imperfecta type VI.
    Hoyer-Kuhn H; Netzer C; Koerber F; Schoenau E; Semler O
    Orphanet J Rare Dis; 2014 Sep; 9():145. PubMed ID: 25257953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in patients with osteogenesis imperfecta from consanguineous Indian families.
    Stephen J; Girisha KM; Dalal A; Shukla A; Shah H; Srivastava P; Kornak U; Phadke SR
    Eur J Med Genet; 2015 Jan; 58(1):21-7. PubMed ID: 25450603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individualized treatment with denosumab in children with osteogenesis imperfecta - follow up of a trial cohort.
    Hoyer-Kuhn H; Rehberg M; Netzer C; Schoenau E; Semler O
    Orphanet J Rare Dis; 2019 Sep; 14(1):219. PubMed ID: 31533771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biallelic variants in four genes underlying recessive osteogenesis imperfecta.
    Hayat A; Hussain S; Bilal M; Kausar M; Almuzzaini B; Abbas S; Tanveer A; Khan A; Siddiqi S; Foo JN; Ahmad F; Khan F; Khan B; Anees M; Mäkitie O; Alfadhel M; Ahmad W; Umair M
    Eur J Med Genet; 2020 Aug; 63(8):103954. PubMed ID: 32413570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mouse model for human osteogenesis imperfecta type VI.
    Bogan R; Riddle RC; Li Z; Kumar S; Nandal A; Faugere MC; Boskey A; Crawford SE; Clemens TL
    J Bone Miner Res; 2013 Jul; 28(7):1531-6. PubMed ID: 23413146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of FKBP10, SERPINH1, and SERPINF1 genes in patients with osteogenesis imperfecta.
    Barbirato C; Trancozo M; Rebouças MR; Sipolatti V; Nunes VR; Paula F
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI.
    Seale E; Molina MO; Carsen S; Sheffield H; Koujok K; Robinson ME; Feber J; Smit K; Page M; Walker S; Khan N; Konji VN; Rauch F; Ward LM
    Calcif Tissue Int; 2023 May; 112(5):613-620. PubMed ID: 36867194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.
    Fratzl-Zelman N; Schmidt I; Roschger P; Roschger A; Glorieux FH; Klaushofer K; Wagermaier W; Rauch F; Fratzl P
    Bone; 2015 Apr; 73():233-41. PubMed ID: 25554599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and molecular analysis in families with autosomal recessive osteogenesis imperfecta identifies mutations in five genes and suggests genotype-phenotype correlations.
    Caparrós-Martin JA; Valencia M; Pulido V; Martínez-Glez V; Rueda-Arenas I; Amr K; Farra C; Lapunzina P; Ruiz-Perez VL; Temtamy S; Aglan M
    Am J Med Genet A; 2013 Jun; 161A(6):1354-69. PubMed ID: 23613367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Denosumab for Osteoporosis in Three Female Patients with Osteogenesis Imperfecta.
    Uehara M; Nakamura Y; Takahashi J; Kamimura M; Ikegami S; Suzuki T; Uchiyama S; Yamaguchi T; Kosho T; Kato H
    Tohoku J Exp Med; 2017 Jun; 242(2):115-120. PubMed ID: 28626166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.
    Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R
    J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial.
    Hoyer-Kuhn H; Franklin J; Allo G; Kron M; Netzer C; Eysel P; Hero B; Schoenau E; Semler O
    J Musculoskelet Neuronal Interact; 2016 Mar; 16(1):24-32. PubMed ID: 26944820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Denosumab in Children With Osteogenesis Imperfecta-the First Prospective Comparative Study.
    Liu J; Lin X; Sun L; Zhang Q; Jiang Y; Wang O; Xing X; Xia W; Li M
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1827-1836. PubMed ID: 38198649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-Exome Sequencing Identifies an Intronic Cryptic Splice Site in
    Jin Z; Burrage LC; Jiang MM; Lee YC; Bertin T; Chen Y; Tran A; Gibbs RA; Jhangiani S; Sutton VR; Rauch F; Lee B; Jain M
    JBMR Plus; 2018 Jul; 2(4):235-239. PubMed ID: 30283904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mutations of noncollagen genes in osteogenesis imperfecta--implications of the gene products in collagen biosynthesis and pathogenesis of disease].
    Galicka A
    Postepy Hig Med Dosw (Online); 2012 Jun; 66():359-71. PubMed ID: 22706122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.
    Marini JC; Reich A; Smith SM
    Curr Opin Pediatr; 2014 Aug; 26(4):500-7. PubMed ID: 25007323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.